Area of expertise: Approval pathways and commercialization of antibacterial drugs

Mark J. Goldberger

Mark J. Goldberger

Independant Consultant
more
Aaron Kesselheim

Aaron Kesselheim

Professor of Medicine
Brigham and Women's Hospital/Harvard Medical School, USA
more
Christopher M. Longshaw

Christopher M. Longshaw

Senior Director, Scientific Affairs.
Shionogi B.V.
more
Jean-Pierre Paccaud

Jean-Pierre Paccaud

AMR and Global Health Senior Advisor
GARDP
more
John Rex

John Rex

Chief Medical Officer
F2G LTD.
more
Carole Sable

Carole Sable

Principle
CA Sable Consulting, LLC
more
David Shlaes

David Shlaes

Former Director, Anti-Infectives Consulting
Former Professor of Medicine, Case Western Reserve University
more
Luka Srot

Luka Srot

Associate Director, Health Security
IFPMA
more
Markus Zeitlinger

Markus Zeitlinger

Head of the Department of Clinical Pharmacology
Medical University of Vienna
more

Newsletter

Subscribe to our newsletter to stay up-to-date about our webinars, conferences and other activities.



View previous newsletters

Go to Top